The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer.

International journal of oncology

Volumn 21, Issue 5, 2002, Pages 929-933

  Sellar, Grant C ^a   Watt, Karen P ^a   Li, L ^a   Nelkin, Barry D ^a   Rabiasz, Genevieve J ^a   Porteous, David J ^a   Smyth, John F ^a   Gabra, Hani ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARX2 PROTEIN, HUMAN; CISPLATIN; HOMEODOMAIN PROTEIN;

ARTICLE; CELL CULTURE; DRUG RESISTANCE; FEMALE; GENETIC TRANSFECTION; GENETICS; HOMEOBOX; HUMAN; NEOPLASM; NORTHERN BLOTTING; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY;

BLOTTING, NORTHERN; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0036835860     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.21.5.929     Document Type: Article

References (0)